BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  Arrowhead Pharmaceuticals Presents Interim Clinical Data on ARO-CFB for the Treatment of Complement Mediated Diseases

  December 11, 2024

   · 

  7 min read
• Press Releases

  Angitia Biopharmaceuticals Announces $120 Million Series C Financing

  December 11, 2024

   · 

  4 min read
• Press Releases

  Kazia Therapeutics to Present Data Highlighting Synergistic Activity Between Paxalisib and Immunotherapy in Immunotherapy-Resistant Triple Negative Breast Cancer Model at the San Antonio Breast Cancer Symposium

  December 11, 2024

   · 

  6 min read
• Press Releases

  NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma

  December 11, 2024

   · 

  4 min read
• Press Releases

  Astria Therapeutics Announces Positive Final Results from Target Enrollment in the ALPHA-STAR Phase 1b/2 Trial of Navenibart for HAE

  December 11, 2024

   · 

  10 min read
• Press Releases

  Sparrow Pharmaceuticals Collaborates with the University of Oxford and the University of Sheffield on DC-MACS, a Phase 2 Clinical Study of Clofutriben

  December 11, 2024

   · 

  4 min read
• Press Releases

  Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference

  December 11, 2024

   · 

  1 min read
• Press Releases

  Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis

  December 11, 2024

   · 

  5 min read
• Press Releases

  Aprea Therapeutics Announces Twice Daily (BID) Dosing of Patients in ABOYA-119 Clinical Trial of ATRN-119 to Potentially Optimize Clinical Outcomes and Strengthen Clinical Path Forward

  December 11, 2024

   · 

  7 min read
• Press Releases

  Trinity Life Sciences Appoints Jonathan Jenkins From McKinsey’s QuantumBlack to Head up Its Digital & AI Initiatives

  December 11, 2024

   · 

  2 min read